Company intelligence / Profile preview

Max Biocare

South Yarra, Victoria, Australiamaxbiocare.com ↗

Ownership: Private
Employees: ~53
Development stage: Commercial

Overview

Max Biocare develops and markets scientifically validated natural medicines, nutraceuticals, and wellness products. All therapeutic formulas are regulated by the Australian Therapeutic Goods Administration (TGA) and manufactured under GMP standards. The company has over two decades of experience as an international innovator in bioscience and healthcare. No clinical trial results or prescription pharmaceuticals are reported.

Therapeutic areas: Other
Modalities: Small moleculeProteinNon-pharmacological therapy
Industry: Food & Nutrition

Drug pipeline

1 asset

Maxucosa

Commercial

Indications: Immune health, Skin health, Inflammation

Beyond the preview

Go deeper on Max Biocare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Max Biocare.

Explore the full profile